MedTech Industry Dynamics
MedTech Industry Dynamics
GE HealthCare has introduced three additions to its Vivid cardiovascular ultrasound portfolio — Vivid Explorer, Vivid Advanced, and Vivid Focus — designed to address distinct imaging and workflow needs across routine echocardiography, comprehensive cardiac imaging, and interventional care.
詳細情報Abbott has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder, a next-generation device designed to reduce stroke risk in patients with non-valvular atrial fibrillation, featuring design updates for improved conformability and sealing.
詳細情報ZEISS Medical Technology has introduced a dedicated cataract-only configuration of the DORC EVA NEXUS ophthalmic surgical system, featuring cataract grade selection, advanced fluidics, and SMART IOP technology for streamlined performance and control in cataract surgery.
詳細情報Olympus has announced the full commercial launch of the POWERSEAL Open Extended Jaw Sealer/Divider in the United States and Canada, a one-hand-operable surgical energy device indicated for sealing vessels up to 7mm in diameter across colorectal, gynecological, thoracic, urological, and vascular procedures.
詳細情報Philips and Imricor have introduced a new Interventional MR lab solution combining Philips’ 1.5T MRI platform with Imricor’s MR-compatible systems and consumables, enabling an MR-guided workflow for cardiac intervention without compromising on MR field strength.
詳細情報QIAGEN has launched QIAsymphony Connect, an IVD-compliant automated platform for clinical nucleic acid extraction that builds on more than 3,300 cumulative placements of the established QIAsymphony platform while using the same reagent kits and consumables.
詳細情報Paradromics has received FDA approval to expand the types of computing devices that may be used with its investigational brain-computer interface (BCI) system in the Connect-One clinical study, enabling compatibility with personal laptops, tablets, and phones through its Convey user interface.
詳細情報Abbott has received FDA De Novo authorization for its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensing technology designed to monitor glucose and detect rising ketone levels that can lead to diabetic ketoacidosis in people with diabetes.
詳細情報Roche has received FDA clearance for its Elecsys pTau217 blood test, the first and only FDA-cleared single-biomarker test supporting both rule-in and rule-out assessment of amyloid pathology. Quest Diagnostics and Labcorp will offer the test to clinicians nationwide.
詳細情報Genesis MedTech has received NMPA approval for its RuiZhi Ultra intelligent powered endoscopic stapler, featuring AI-enabled tissue-adaptive feedback for precise staple formation, following CE certification in April.
詳細情報
